Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to Ngs Genetic Dna Test
BMPR1A Gene Polyposis Syndrome Hereditary Mixed Type 2 NGS Genetic DNA Test BMPR1A Gene Polyposis Syndrome Hereditary Mixed Type 2 NGS Genetic DNA Test Original price was: KSh 56,000.00.Current price is: KSh 40,000.00.
Acute Leukemia Mini Panel AMLETO INV16 PMLRARA BCRABL TELAML1 MLL E2A Acute Leukemia Mini Panel AMLETO INV16 PMLRARA BCRABL TELAML1 MLL E2A Original price was: KSh 26,000.00.Current price is: KSh 19,500.00.
Sale!

Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to Ngs Genetic Dna Test

Original price was: KSh 56,000.00.Current price is: KSh 40,000.00.

-29%

The Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test is crucial for assessing genetic predisposition to thyroid cancer. Priced at KSh 40,000, it offers insights that can guide preventive measures and treatment options. This test is particularly recommended for individuals with a family history of thyroid cancer or those showing symptoms associated with the disease.

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to Ngs Genetic Dna Test
Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to Ngs Genetic Dna Test
KSh 56,000.00 Original price was: KSh 56,000.00.KSh 40,000.00Current price is: KSh 40,000.00.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test

Introduction to the Test

The Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test is a specialized genetic test that evaluates an individual’s susceptibility to developing nonmedullary thyroid cancer associated with the SRGAP1 gene. Understanding your genetic predisposition is essential for early intervention and personalized treatment strategies, making this test a vital tool for those at risk.

What the Test Measures

This test specifically detects mutations or alterations in the SRGAP1 gene that may contribute to the development of thyroid cancer. By utilizing Next Generation Sequencing (NGS) technology, it provides a comprehensive analysis of genetic variations that could indicate an increased risk of cancer.

Who Should Consider This Test?

Individuals who should consider the Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test include:

  • Those with a family history of thyroid cancer.
  • Individuals experiencing symptoms such as a lump in the neck, difficulty swallowing, or changes in voice.
  • Patients with known genetic predispositions to cancer.

Benefits of Taking the Test

Taking the Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test offers several benefits:

  • Early identification of genetic risks associated with thyroid cancer.
  • Informed decision-making regarding monitoring and preventive measures.
  • Personalized treatment plans based on genetic insights.
  • Access to genetic counseling for better understanding and support.

Understanding Your Results

After undergoing the test, results will be provided within 3 to 4 weeks. A genetic counseling session is recommended to help interpret the results and discuss potential next steps. Understanding your results is crucial for making informed health decisions.

Test Pricing

Test Name Discount Price Regular Price
Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test 40,000 KSh 56,000 KSh

Book Your Test Today

We have branches across major cities in Kenya and offer home sample collection services for your convenience. To book the Srgap1 Gene Thyroid Cancer Type 2 Nonmedullary Susceptibility to NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.

SKU: 8d3215ae9759 Category:

Related products